Investor Presentaiton
Overview of Argon's Performance
A
ARGON
MEDICAL DEVICES
As Weigao's core overseas
platform, Argon has been an
important part of Weigao's
growth since the acquisition,
aiding Weigao in diversifying in
both geography and product mix.
Continued initiatives across
Weigao and Argon are currently
underway; we believe the
collaboration between Weigao
and Argon will continue to be a
key growth catalyst for both
companies in the coming years.
Financial
Performance
Argon China
Future Strategy
•
.
.
In 1H2020, Argon recorded total sales RMB678.3m, representing a
3.8% decrease y-o-y. While sales declined slightly when compared
to 1H2019, Argon's net profit continued to record consistent growth.
China has been pinpointed as one of Argon's key growth regions
going forward; Argon aims to create synergies with Weigao's vast
network and local expertise to rapidly grow its presence in China in
the coming years.
In 1H2020, Argon continued to make strides in establishing its sales
& distribution network, laying the foundations for future rapid growth.
•
To capitalize on the vast market potential of China in order to further
expand Argon's global coverage and scale.
To continue develop innovative products and supplement its
existing product portfolio.
WEGO威高
12View entire presentation